Tag: Merck

By Andrew Silver SHANGHAI (Reuters) -Pharmaceutical research and development firms in China are increasingly interested in procuring critical supplies known ...

Merck (MRK -1.91%), a leading pharmaceutical company, generates consistent revenue and profits. However, the stock has been under pressure over ...

(Reuters) -Merck is acquiring UK-based Verona Pharma for about $10 billion, as part of the U.S. drugmaker's strategy to diversify ...

(Reuters) -Merck (MRK) will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. ...

(Reuters) -Merck is nearing a roughly $10 billion deal to buy lung disease-focused biotech Verona Pharma, the Financial Times reported ...

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...

(Reuters) -Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported ...

Courtesy of Merck; Karan Singh for BI Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and ...

Researchers, in a sense, manipulated each patient’s cancer in an attempt to prevent it from coming back. Read More

Shares of Merck (MRK -9.62%) were trading lower on Tuesday. The company's stock had lost 10.1% as of 2 p.m. ...